James Garbutt is a Psychiatry physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 144 publications with 6,001 citations (h-index 34); ClinicalTrials.gov lists 8 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Buproprion for Binge Drinking
Sponsor: University of North Carolina, Chapel Hill
- An Open Label Trial of Bupropion and Naltrexone for Binge Drinking
Sponsor: University of North Carolina, Chapel Hill
- Oxytocin Treatment of Opioid Dependence
Sponsor: University of North Carolina, Chapel Hill
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Partial Opioid Agonist53.3%Buprenorphine-Naloxone100%Part D<11 patientsSNRI46.7%Duloxetine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
9 NIH research awards on record, funded 1990–2018 per NIH RePORTER. The latest:
- Intranasal Oxytocin Treatment for Alcohol Use Disorders: A Randomized, Placebo-Controlled Trial
Univ of North Carolina Chapel Hill
FY2018$409,425R01AA025942 - Efficacy and Safety of the Melanocortin Activator Bupropion in Treating Binge Drinking
Univ of North Carolina Chapel Hill
FY2018$218,500R21AA025186 - Efficacy and Safety of the Melanocortin Activator Bupropion in Treating Binge Drinking
Univ of North Carolina Chapel Hill
FY2017$180,500R21AA025186
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Robert Sandler, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Hyman Muss, MD
University of North Carolina at Chapel Hill
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”